Order results by:
| Issue | Title | |
| Vol 12, No 2 (2016) | PLEIOTROPIC EFFECTS OF VITAMIN D | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... Review of clinical studies showing the pleiotropic effect of vitamin D with a detailed description ..." | ||
| Vol 11, No 6 (2015) | Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? | Abstract similar documents |
| I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov | ||
| "... A hypothesis that possible pleiotropic features of different statins could be explained ..." | ||
| Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
| L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
| "... parathyroidectomy. Conclusion. The pleiotropic effects (reduction in BP and atherogenic lipids levels, as well ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... after 24 weeks in the both groups. Conclusion. The revealed lipid-lowering and pleiotropic effects ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... with pleiotropic effect in patients with arterial hypertension and associated diseases (diabetes mellitus, obesity ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... B12 deficiency. Aim. To evaluate the effect of FA, B6 and B12 vitamins (in doses approximate ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| "... drug which has pleiotropic effects involving into the atherosclerosis progression. ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... Data on the effect of magnesium on the homeostasis of the body and on the cardiovascular system ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... for knowledge of their pleiotropic effects. The article presents the results of studies of the effect ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... , and some pleiotropic effects are also presented. ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... Disorder of formation of vitamin B12, which has a wide range of biological properties ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... and, in particular, on the cardiovascular system. It describes the importance of the presence and effects ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| "... are discussed. ASA interaction with other drugs and ASA pleiotropic effects are reviewed ..." | ||
| Vol 2, No 3 (2006) | EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS | Abstract similar documents |
| A. P. Momot, O. V. Bespalova, E. N. Vorobyova | ||
| "... and acquired (secondary) thrombophilie. The contents of vitamin К1 in nutrition depend on a method of product ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... the necessity of knowledge of their pleiotropic effects. Results of studies of the effect of cardiac drugs ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... pleiotropic effects due to independent metabolic activity of orotic acid. ..." | ||
| Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
| N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
| "... , activated charcoal) could impair the absorption of warfarin, increase intestinal absorption of vitamin K ..." | ||
| Vol 7, No 2 (2011) | CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE | Abstract similar documents |
| M. V. Leonova | ||
| "... pleiotropic effect (influence on endothelial function and antiatherogenic action) is presented. Amlodipine ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... forms of ischemic heart disease (IHD). Pleiotropic effects, in particular, effect on endothelial ..." | ||
| Vol 6, No 3 (2010) | CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| V. N. Larina, B. Ya. Bart, V. G. Larin | ||
| "... . Причиной развития анемии у 35,8% больных был дефицит железа, у 9,4% — дефицит витамина В12, у 15 ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... the effects of unfractionated heparin, low molecular weight heparins, vitamin K antagonists, oral ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... to clinical guidelines vitamin K antagonists (VKAs) should be used as treatment of choice for thrombus ..." | ||
| Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
| I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
| "... in parasympathetic activity. Simvastatin potentiated fosinopril positive effects on left ventricular hypertrophy ..." | ||
| Vol 5, No 2 (2009) | POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh | ||
| "... (BMD) and to evaluate it pleiotropic effects on cardiovascular remodeling in women with postmenopausal ..." | ||
| Vol 19, No 6 (2023) | Place of imidazoline receptor agonists in the treatment of arterial hypertension | Abstract similar documents |
| D. V. Nebieridze, A. S. Safaryan, E. I. Ivanova, E. A. Poddubskaya | ||
| "... that an important property of AIR is its positive effect on carbohydrate and lipid metabolism. This information ..." | ||
| Vol 13, No 6 (2017) | FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES | Abstract similar documents |
| D. А. Napalkov, A. A. Sokolova | ||
| "... studies allows one to more reliably talk about the pleiotropic effects of amlodipine and to determine its ..." | ||
| Vol 15, No 4 (2019) | According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | Abstract similar documents |
| Company Pfizer | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... , it was found that ω-3 PUFAs have a variety of pleiotropic effects: they reduce the formation of oxygen radicals ..." | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... implementation of pleiotropic effects of statins can be attributed to the latter. The authors clearly demonstrate ..." | ||
| Vol 13, No 6 (2017) | THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| A. N. Zakirova, B. N. Garifullin, N. E. Zakirova | ||
| "... in experimental data. Carvedilol is a third-generation beta-blocker with additional pleiotropic and antioxidant ..." | ||
| Vol 14, No 4 (2018) | New Clinical Aspects of Eplerenone Use in Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina | ||
| "... , which may indicate the pleiotropic effects of eplerenone in patients with vascular diseases ..." | ||
| Vol 18, No 6 (2022) | The Pathogenetic Basis of the Action of Bempedoic Acid | Abstract similar documents |
| A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin | ||
| "... of these classes will have similar side effects and pleiotropic effects associated with modulation of the mevalonic ..." | ||
| Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
| P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
| "... of three components (lisinopril, amlodipine and rosuvastatin), each of which has pleiotropic effects ..." | ||
| Vol 16, No 6 (2020) | Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences? | Abstract similar documents |
| A. I. Kochetkov | ||
| "... feature of indapamide is also the presence, in addition to the direct diuretic effect, pleiotropic ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct ..." | ||
| Vol 15, No 5 (2019) | Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
| "... Direct oral anticoagulants (not vitamin K antagonists), unlike standard oral anticoagulants (e ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... , in the early postoperative period after orthopedic surgery. Nowadays it is possible to use vitamin K ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| "... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... after coronary artery bypass grafting (CABG), as well as to evaluate the effect of sodium-glucose ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose benefits are long established ..." | ||
| Vol 19, No 5 (2023) | Daily breakfast: will skipping a morning meal become a new prognostic marker? | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina | ||
| "... . The effect of breakfast on the depression risk, which is an independent marker of cardiovascular diseases ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 18, No 2 (2022) | The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects | Abstract similar documents |
| N. B. Lebedeva, L. Yu. Chesnokova | ||
| "... , main hemodynamic effects, clinical trials and obtained evidences that have formed the basis ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... 4 or 5 chronic kidney disease" or "stage 5 chronic kidney disease" and "non-vitamin K antagonist ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... the dynamics of cardiovascular mortality during the year: seasonal fluctuations in the level of vitamin D ..." | ||
| Vol 17, No 3 (2021) | Intestinal Microbial-tissue Complex and Chronic Heart Failure (part 1): Pathogenesis | Abstract similar documents |
| A. A. Vlasov, S. P. Salikova, N. V. Golovkin, V. B. Grinevich | ||
| "... . Besides, a decrease in the production of short-chain and polyunsaturated fatty acids and vitamins ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
| Vol 4, No 3 (2008) | URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES | Abstract similar documents |
| M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov | ||
| "... Aim. To compare urodynamic effects of beta-blockers with different selectivity (propranolol ..." | ||
| Vol 1, No 2 (2005) | ESTIMATION OF ANTIHYPERTENSIVE EFFECT EQUABILITY FOR TWO PRESENTATIONS OF NIFEDIPINE WITH DAILY BLOOD PRESSURE MONITORING | Abstract similar documents |
| V. M. Gorbunov, E. V. Alimova, A. D. Deev | ||
| "... Aim. To compare information value of antihypertensive effect equability parameters for two drug ..." | ||
| Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
| Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
| "... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... ) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... drug should not only have an adequate hypoglycemic effect, but also have a number of cardioprotective ..." | ||
| Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... , rivaroxaban, apixaban, and edoxaban) over the vitamin K antagonist warfarin in elderly patients with geriatric ..." | ||
| Vol 18, No 5 (2022) | The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case | Abstract similar documents |
| O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova | ||
| "... interaction potential. Rhabdomyolysis is a known side effect of statin therapy, and there is evidence that co ..." | ||
| Vol 12, No 4 (2016) | Organoprotective effects of serelaxin in patients with severe decompensated heart failure | Abstract similar documents |
| Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai | ||
| "... the symptoms of heart failure, provide a significant reduction in congestion and have a protective effect ..." | ||
| Vol 12, No 6 (2016) | THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev | ||
| "... Aim. To assess the effect of nicorandil added to the standard therapy of patients with stable ..." | ||
| Vol 5, No 5 (2009) | LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE | Abstract similar documents |
| M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova | ||
| "... Aim. To estimate cardiorenoprotective effect of 12-month therapy by indapamide in elderly ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
| M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
| "... Aim. To study the antihypertensive and metabolic effects of lisinopril plus amlodipine combination ..." | ||
| Vol 6, No 4 (2010) | CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION | Abstract similar documents |
| O. V. Gaisenok | ||
| "... for atrial fibrillation treatment. Various side effects of this drug including amiodarone-induced ..." | ||
| Vol 6, No 6 (2010) | THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS | Abstract similar documents |
| O. V. Gaisenok | ||
| "... of action and its pro-arrhythmic effect is presented. As well as various side effects that can happen ..." | ||
| Vol 16, No 3 (2020) | Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs | Abstract similar documents |
| O. V. Gaisenok | ||
| "... and side effects of co-administration of chloroquine/hydroxychloroquine and azithromycin, considering ..." | ||
| Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
| Z M. Sizova | ||
| "... of antihypertensive therapy in stroke patients are presented in the article. ARBs are original drugs that effect ..." | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| "... of sartans, not only as a drug with proven antihypertensive effect, but also in terms of their effects ..." | ||
| Vol 8, No 3 (2012) | CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS | Abstract similar documents |
| V. P. Volkov | ||
| "... effects of antipsychotic drugs. ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... Aim. To compare antihypertensive and metabolic effects of long-term treatment with carvedilol ..." | ||
| Vol 19, No 5 (2023) | White coat effect in patients with hypertension | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova | ||
| "... The article is devoted to various aspects of white coat effect (WCE) in patients with hypertension ..." | ||
| Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
| N. V. Perova | ||
| "... acute episodes as well as stroke depending on treatment duration. Effect of LDL cholesterol reduction ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... ranges. Conclusion. Clopidogrel has not only antithrombotic effect but also can diminish platelets ..." | ||
| Vol 7, No 6 (2011) | EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS | Abstract similar documents |
| V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova | ||
| Vol 5, No 1 (2009) | DOPAMINE EFFECT ON CARDIAC REMODELING IN EXPERIMENT | Abstract similar documents |
| V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, I. A. Suchenko, V. E. Goricina, T. M. Nurjanova | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... , on the contrary, can have a positive effect on the course of primary headaches. Antihypertensive drugs reduce ..." | ||
| Vol 20, No 3 (2024) | NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management | Abstract similar documents |
| P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina | ||
| "... with cardiovascular outcomes. New clinically relevant pleotorpic effects of statins, sodium-glucose cotransporter-2 ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..." | ||
| Vol 11, No 2 (2015) | MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS | Abstract similar documents |
| L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov | ||
| "... Aim. To study the effect of magnesium orotate, magnesium/pyridoxine combination and magnesium ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... have been shown that the use of DOACs, as compared to vitamin K antagonists, is a more rational ..." | ||
| Vol 17, No 4 (2021) | Medium-term Effects of Enhanced External Counterpulsation in the Structural and Functional Parameters of Blood Vessels in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| K. S. Karaganov, O. A. Slepova, A. S. Lishuta, N. I. Solomakhina, Yu. N. Belenkov | ||
| "... Aim. To study the mid-term effects of enhanced external counterpulsation (EECP) in the structural ..." | ||
| Vol 18, No 5 (2022) | A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, I. R. Oleinik, O. L. Barbarash | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... reduces HR, and much less causes headache and other side effects. ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... Aim. To compare antihypertensive and metabolic effects as well as influence on erectile function ..." | ||
| Vol 14, No 5 (2018) | Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” | Abstract similar documents |
| N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich | ||
| Vol 17, No 2 (2021) | Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma | Abstract similar documents |
| G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
| "... Aim. To study the main relationships of the white coat effect (WCE) levels in patients ..." | ||
| Vol 15, No 2 (2019) | How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine? | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 19, No 2 (2023) | Vasotoxic Effects of Anticancer Therapy: a Review of Current Data | Abstract similar documents |
| Yu. A. Vasyuk, E. Y. Shupenina, A. G. Nosova, E. O. Novosel, D. A. Vyzhigin | ||
| "... have appeared on the possible vasotoxic effects of chemotherapy drugs, which can manifest themselves ..." | ||
| Vol 5, No 2 (2009) | ASSESSMENT OF AMLODIPINE ANTIHYPERTENSIVE EFFECT HOMOGENEITY IN CONTROLLED TRIAL | Abstract similar documents |
| V. M. Gorbunov, M. I. Smirnova, A. D. Deev | ||
| "... , including antihypertensive effect smoothness in patients with arterial hypertension (HT). Methods. 39 ..." | ||
| Vol 13, No 3 (2017) | EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY | Abstract similar documents |
| V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
| "... . Amlodipine, fosinopril and metoprolol had similar antihypertensive effect. Amlodipine was more effective ..." | ||
| Vol 5, No 1 (2009) | CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA | Abstract similar documents |
| A. Ya. Kravchenko, V. M. Provotorov | ||
| Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
| S. G. Shulkina, Е. N. Smirnova | ||
| Vol 2, No 3 (2006) | HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. I. Markova, A. I. Radzevich | ||
| "... , and ultrasound Dopplerography of extra cranial vessels. Results. A normalizing effect of carvedilol on abnormal ..." | ||
| Vol 2, No 3 (2006) | ORGANOPROTECTIVE EFFECTS OF BENASEPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. S. Zadionchenko, T. V. Adasheva, A. M. Shamshinova, I. Y. Malishev, E. B. Manukhina, A. Y. Bogolyubskaya, K. M. Golovanov, M. A. Arakelyan, O. L. Silakova | ||
| "... effects on microcirculation, endothelium function, system of cytoprotection, ophthalmoscopic ..." | ||
| 1 - 100 of 679 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
